Corbus Pharmaceuticals Holdings, Inc. (CRBP) Investor Relations Documents

Corbus Pharmaceuticals Holdings, Inc. (CRBP) investor relations documents from the company's IR site: 1 presentation, 28 press releases; latest deck 2026-06-18. Read in-app with summaries. First-party data.

Corporate Presentation: Corbus Pharmaceuticals' June 2026 presentation highlights CRB-701, a Nectin-4 ADC showing 42.9% cORR in 2L+ OPSCC patients at the 3.6 mg/kg dose.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-17Press releaseCorbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06Press releaseCorbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
2026-08-04Press releaseCorbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
2026-07-28Press releaseCorbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L O
2026-07-06Press releaseCorbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
2026-06-18PresentationCorporate Presentation
2026-05-26Press releaseCorbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal
2026-05-26Press releaseDownload as PDF
2026-05-21Press releaseCorbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 AS
2026-05-14Press releaseCorbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
2026-05-13Press releaseCorbus Pharmaceuticals to Participate in Upcoming Investor Conferences
2026-05-12Press releaseCorbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
2026-05-12Press releaseDownload as PDF
2026-05-05Press releaseCorbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026
Press releaseCorbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
2026-02-12Press releaseCorbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Press releaseCorbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
2025-03-11Press releaseCorbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
2024-11-07Press releaseCorbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
2024-08-06Press releaseCorbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
2024-05-07Press releaseCorbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
2024-03-12Press releaseCorbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
2023-11-07Press releaseCorbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-08-08Press releaseEarnings ReleaseHTML
2023-05-09Press releaseEarnings ReleaseHTML
2023-03-07Press releaseEarnings ReleaseHTML
2022-11-08Press releaseEarnings ReleaseHTML
2022-08-09Press releaseEarnings ReleaseHTML
2022-05-10Press releaseEarnings ReleaseHTML

CRBP overview · CRBP earnings · CRBP financials · CRBP KPIs · CRBP ownership · CRBP peers · CRBP filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.